IDEXX Laboratories, Inc. (LON:0J8P)
408.18
-9.78 (-2.34%)
Mar 13, 2025, 7:18 PM BST
IDEXX Laboratories Revenue
In the year 2024, IDEXX Laboratories had annual revenue of $3.90B USD with 6.46% growth. IDEXX Laboratories had revenue of $954.29M in the quarter ending December 31, 2024, with 5.84% growth.
Revenue
$3.90B
Revenue Growth
+6.46%
P/S Ratio
n/a
Revenue / Employee
$354.32K
Employees
11,000
Market Cap
25.52B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.90B | 236.55M | 6.46% |
Dec 31, 2023 | 3.66B | 293.63M | 8.72% |
Dec 31, 2022 | 3.37B | 151.96M | 4.73% |
Dec 31, 2021 | 3.22B | 508.71M | 18.79% |
Dec 31, 2020 | 2.71B | 299.75M | 12.45% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 43.19B |
GSK plc | 31.38B |
Haleon | 11.23B |
Smith & Nephew | 4.64B |
ConvaTec Group | 1.83B |
Hikma Pharmaceuticals | 2.50B |
HUTCHMED (China) | 483.31M |
Genus | 671.60M |
IDEXX Laboratories News
- 2 days ago - IDEXX Laboratories: A Top Dog In The Pet Care Market - Seeking Alpha
- 20 days ago - Decoding IDEXX Laboratories Inc (IDXX): A Strategic SWOT Insight - GuruFocus
- 4 weeks ago - IDEXX Laboratories Inc (IDXX) Announces Participation in Upcoming Investor Conferences - GuruFocus
- 4 weeks ago - IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences - Business Wire
- 4 weeks ago - Options Movement At IDEXX Laboratories: Michael G Erickson Exercises Worth $597K - Benzinga
- 4 weeks ago - Insider Decision: George Fennell Exercises Options At IDEXX Laboratories For $4.28M - Benzinga
- 4 weeks ago - M. Anne Szostak Implements A Sell Strategy: Offloads $1.40M In IDEXX Laboratories Stock - Benzinga
- 4 weeks ago - IDEXX Laboratories And Its Real Value - Seeking Alpha